4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-22-000026
Chief Medical Officer sold 106 shares at $15.01 ($1,591)
- Chief Medical Officer acquired 106 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
KREHER NERISSA · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-09-15 | Exercise or conversion : show line 1 in the form | +106 | $2.10 | $223 | 20,822 | D |
| 2022-09-15 | Sale : show line 2 in the form | −106 | $15.01 | $1,591 | 20,716 | D |
| Open-market sales · 106 sh · avg $15.01 · $1,591 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-09-15 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −106 | 28,905 | D |
Loading xslF345X03/wf-form4_166361953637742.xml…